Dermatological Toxicity in Women With Breast Cancer Undergoing Chemotherapy Treatment

Authors

  • Thais de Oliveira Gozzo Universidade de São Paulo; Escola de Enfermagem de Ribeirão Preto
  • Marislei Sanches Panobianco Universidade de São Paulo; Escola de Enfermagem de Ribeirão Preto
  • Maria José Clapis Universidade de São Paulo; Escola de Enfermagem de Ribeirão Preto
  • Ana Maria de Almeida Universidade de São Paulo; Escola de Enfermagem de Ribeirão Preto

DOI:

https://doi.org/10.1590/S0104-11692010000400004

Keywords:

Drug Therapy, Breast Neoplasms, Extravasation of Diagnostic and Therapeutic Materials, Nursing

Abstract

This study aimed to analyze the occurrence of skin toxicity caused by drugs used in the protocol of neoadjuvant and adjuvant chemotherapy among women with breast cancer. Patient records of 72 women who were subject to this therapy between 2003 and 2006 were assessed. Of the 558 cycles of chemotherapy, 152 adverse events were registered. There were 37 registrations of dermatological toxicity, of those, 20 were extravasations that affected 17 women. Nine reports of hardened local injury, local fibrosis, pain, and hyperemia were registered during neoadjuvancy. In adjuvancy, among the 11 extravasations registered there were reports of hardened local injury, fibrosis and local pain. Lack of follow-up records for both periods was observed. Registration of the events and reports by the nursing team are essential to monitor the sites of venous puncture during the chemotherapy treatment, besides measuring and making a photographic record of the site.

Downloads

Download data is not yet available.

Downloads

Published

2010-08-01

Issue

Vol. 18 No. 4 (2010)

Section

Original Articles

License

RLAE’s authorship concept is based on the substantial contribution by each of the individuals listed as authors, mainly in terms of conceiving and planning the research project, collecting or analyzing and interpreting data, writing and critical review. Indication of authors’ names under the article title is limited to six. If more, authors are listed on the online submission form under Acknowledgements. The possibility of including more than six authors will only be examined on multicenter studies, considering the explanations presented by the authors.
Including names of authors whose contribution does not fit into the above criteria cannot be justified. Those names can be included in the Acknowledgements section.
 Authors are fully responsible for the concepts disseminated in their manuscripts, which do not necessarily reflect the editors’ and editorial board’s opinion.

 

How to Cite

Dermatological Toxicity in Women With Breast Cancer Undergoing Chemotherapy Treatment . (2010). Revista Latino-Americana De Enfermagem, 18(4), 681-687. https://doi.org/10.1590/S0104-11692010000400004